NJ A1845 | 2022-2023 | Regular Session
Note: Carry Foward to future A1909
Note: Carry Over of previous A3536
Note: Carry Over of previous A3536
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
Title
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
Sponsors
Rep. Ellen Park [D] |
History
Date | Chamber | Action |
---|---|---|
2022-01-11 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A1845 (Carry Over) 2022-01-11 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A3536 (Carry Over) 2020-02-25 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A3536 (Carry Over) 2020-02-25 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2022/A1845 |
Text | https://pub.njleg.gov/Bills/2022/A2000/1845_I1.HTM |